315 related articles for article (PubMed ID: 21312335)
1. Fabrication and characterization of poly(lactic-co-glycolic acid) microsphere/amorphous calcium phosphate scaffolds.
Popp JR; Laflin KE; Love BJ; Goldstein AS
J Tissue Eng Regen Med; 2012 Jan; 6(1):12-20. PubMed ID: 21312335
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of osteoblastic differentiation on amorphous calcium phosphate-decorated poly(lactic-co-glycolic acid) scaffolds.
Popp JR; Laflin KE; Love BJ; Goldstein AS
J Tissue Eng Regen Med; 2011 Nov; 5(10):780-9. PubMed ID: 22002921
[TBL] [Abstract][Full Text] [Related]
3. Fabrication and characterization of poly(DL-lactic-co-glycolic acid)/zirconia-hybridized amorphous calcium phosphate composites.
Whited BM; Goldstein AS; Skrtic D; Love BJ
J Biomater Sci Polym Ed; 2006; 17(4):403-18. PubMed ID: 16768292
[TBL] [Abstract][Full Text] [Related]
4. Microsphere-based scaffolds encapsulating tricalcium phosphate and hydroxyapatite for bone regeneration.
Gupta V; Lyne DV; Barragan M; Berkland CJ; Detamore MS
J Mater Sci Mater Med; 2016 Jul; 27(7):121. PubMed ID: 27272903
[TBL] [Abstract][Full Text] [Related]
5. Porous hydroxyapatite scaffold with three-dimensional localized drug delivery system using biodegradable microspheres.
Son JS; Appleford M; Ong JL; Wenke JC; Kim JM; Choi SH; Oh DS
J Control Release; 2011 Jul; 153(2):133-40. PubMed ID: 21420453
[TBL] [Abstract][Full Text] [Related]
6. Functionalization of chitosan/poly(lactic acid-glycolic acid) sintered microsphere scaffolds via surface heparinization for bone tissue engineering.
Jiang T; Khan Y; Nair LS; Abdel-Fattah WI; Laurencin CT
J Biomed Mater Res A; 2010 Jun; 93(3):1193-208. PubMed ID: 19777575
[TBL] [Abstract][Full Text] [Related]
7. The effect of bioactive glass content on synthesis and bioactivity of composite poly (lactic-co-glycolic acid)/bioactive glass substrate for tissue engineering.
Yao J; Radin S; S Leboy P; Ducheyne P
Biomaterials; 2005 May; 26(14):1935-43. PubMed ID: 15576167
[TBL] [Abstract][Full Text] [Related]
8. Bone augmentation using a highly porous PLGA/β-TCP scaffold containing fibroblast growth factor-2.
Yoshida T; Miyaji H; Otani K; Inoue K; Nakane K; Nishimura H; Ibara A; Shimada A; Ogawa K; Nishida E; Sugaya T; Sun L; Fugetsu B; Kawanami M
J Periodontal Res; 2015 Apr; 50(2):265-73. PubMed ID: 24966062
[TBL] [Abstract][Full Text] [Related]
9. Facile fabrication of poly(L-lactic acid) microsphere-incorporated calcium alginate/hydroxyapatite porous scaffolds based on Pickering emulsion templates.
Hu Y; Ma S; Yang Z; Zhou W; Du Z; Huang J; Yi H; Wang C
Colloids Surf B Biointerfaces; 2016 Apr; 140():382-391. PubMed ID: 26774574
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of chitosan/poly(lactic acid-glycolic acid) sintered microsphere scaffolds for bone tissue engineering.
Jiang T; Abdel-Fattah WI; Laurencin CT
Biomaterials; 2006 Oct; 27(28):4894-903. PubMed ID: 16762408
[TBL] [Abstract][Full Text] [Related]
11. Facile fabrication of poly(L-lactic acid)-grafted hydroxyapatite/poly(lactic-co-glycolic acid) scaffolds by Pickering high internal phase emulsion templates.
Hu Y; Gu X; Yang Y; Huang J; Hu M; Chen W; Tong Z; Wang C
ACS Appl Mater Interfaces; 2014 Oct; 6(19):17166-75. PubMed ID: 25243730
[TBL] [Abstract][Full Text] [Related]
12. Structural and degradation characteristics of an innovative porous PLGA/TCP scaffold incorporated with bioactive molecular icaritin.
Xie XH; Wang XL; Zhang G; He YX; Wang XH; Liu Z; He K; Peng J; Leng Y; Qin L
Biomed Mater; 2010 Oct; 5(5):054109. PubMed ID: 20876954
[TBL] [Abstract][Full Text] [Related]
13. Enhanced sintering ability of biphasic calcium phosphate by polymers used for bone scaffold fabrication.
Gao C; Yang B; Hu H; Liu J; Shuai C; Peng S
Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):3802-10. PubMed ID: 23910280
[TBL] [Abstract][Full Text] [Related]
14. Fabricating a pearl/PLGA composite scaffold by the low-temperature deposition manufacturing technique for bone tissue engineering.
Xu M; Li Y; Suo H; Yan Y; Liu L; Wang Q; Ge Y; Xu Y
Biofabrication; 2010 Jun; 2(2):025002. PubMed ID: 20811130
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of osteogenic potential of a composite scaffold incorporating either endogenous bone morphogenetic protein-2 or exogenous phytomolecule icaritin: an in vitro efficacy study.
Chen SH; Wang XL; Xie XH; Zheng LZ; Yao D; Wang DP; Leng Y; Zhang G; Qin L
Acta Biomater; 2012 Aug; 8(8):3128-37. PubMed ID: 22543006
[TBL] [Abstract][Full Text] [Related]
16. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA.
Nie H; Wang CH
J Control Release; 2007 Jul; 120(1-2):111-21. PubMed ID: 17512077
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional, bioactive, biodegradable, polymer-bioactive glass composite scaffolds with improved mechanical properties support collagen synthesis and mineralization of human osteoblast-like cells in vitro.
Lu HH; El-Amin SF; Scott KD; Laurencin CT
J Biomed Mater Res A; 2003 Mar; 64(3):465-74. PubMed ID: 12579560
[TBL] [Abstract][Full Text] [Related]
18. Sustained release of platelet-derived growth factor and vascular endothelial growth factor from silk/calcium phosphate/PLGA based nanocomposite scaffold.
Farokhi M; Mottaghitalab F; Ai J; Shokrgozar MA
Int J Pharm; 2013 Sep; 454(1):216-25. PubMed ID: 23856159
[TBL] [Abstract][Full Text] [Related]
19. Pore size regulates cell and tissue interactions with PLGA-CaP scaffolds used for bone engineering.
Sicchieri LG; Crippa GE; de Oliveira PT; Beloti MM; Rosa AL
J Tissue Eng Regen Med; 2012 Feb; 6(2):155-62. PubMed ID: 21446054
[TBL] [Abstract][Full Text] [Related]
20. Porous PLGA scaffolds for controlled release of naked and polyethyleneimine-complexed DNA.
Ravi N; Gupta G; Milbrandt TA; Puleo DA
Biomed Mater; 2012 Oct; 7(5):055007. PubMed ID: 22909549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
